Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2018 Oct 26;25(3):570–576. doi: 10.1016/j.bbmt.2018.10.015

Figure 2. Incidence of TA-TMA after allogeneic transplantation.

Figure 2.

Cumulative incidence (CI) was assessed using the competing risk method where death and disease relapse were treated as competing risks. The overall CI was 7.6% by day 100 post-transplant. CI (100d) was 7% for 1712 patients with first allogeneic transplant and 12% for 433 patients with subsequent transplant. The incidence rates (IR) were highest in the first 100 days. IR (100d) was 73/100,000 person-days in first transplant and 137/100,000 person-days in subsequent transplant.